Inga Mehrani, Matthew Paradise, Lee-Fay Low, Sue Kurrle, Valerie Arsenova, Gemma Jahn, Katrina Fyfe, Johannes C Michaelian, Katharine Salmon, Jane Alty, Sharon L Naismith, Perminder S Sachdev
{"title":"制定,实施和评估澳大利亚第一个国家记忆和认知临床指南。","authors":"Inga Mehrani, Matthew Paradise, Lee-Fay Low, Sue Kurrle, Valerie Arsenova, Gemma Jahn, Katrina Fyfe, Johannes C Michaelian, Katharine Salmon, Jane Alty, Sharon L Naismith, Perminder S Sachdev","doi":"10.1002/trc2.70031","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>A lack of national consensus on the roles and responsibilities of Australian memory and cognition clinics contributes to the large variability seen across services. The introduction of guidelines and a quality assessment framework could facilitate greater harmonization and quality improvements.</p><p><strong>Methods: </strong>We used a modified Delphi process to develop the guidelines. Pilot clinics completed a self-assessment, case-note audit, and review meeting to evaluate their service against the guidelines.</p><p><strong>Results: </strong>The final guidelines included 160 standards on 14 different topics. Standards around maximum waiting times for an assessment and minimum post-diagnostic care responsibilities were particularly controversial. Seven clinics participated in the pilot. On average, clinics achieved 56% of standards (range of 18% to 87%).</p><p><strong>Discussion: </strong>The Memory and Cognition Clinic Guidelines form the first step toward greater harmonization and quality improvements. Key learnings from the clinics' feedback included reducing the number of secondary standards and streamlining data collection with the national dementia clinical quality registry.</p><p><strong>Highlights: </strong>We developed and implemented the first national consensus-based best-practice guidelines for memory and cognition clinics in Australia.The guidelines are based on consultation with 125 Australian health professionals and 89 Australians living with dementia and care partners.First-time national agreement on standards around maximum waiting times for an assessment and minimum post-diagnostic care requirements is presented in the guidelines.The guidelines were implemented in seven memory and cognition clinics from five different states.Clinicians' feedback included: reducing the number of secondary standards to increase conciseness and practicability should be considered for future iterations.</p>","PeriodicalId":53225,"journal":{"name":"Alzheimer''s and Dementia: Translational Research and Clinical Interventions","volume":"11 1","pages":"e70031"},"PeriodicalIF":4.9000,"publicationDate":"2025-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11736619/pdf/","citationCount":"0","resultStr":"{\"title\":\"Developing, implementing, and evaluating the first national Memory and Cognition Clinic Guidelines in Australia.\",\"authors\":\"Inga Mehrani, Matthew Paradise, Lee-Fay Low, Sue Kurrle, Valerie Arsenova, Gemma Jahn, Katrina Fyfe, Johannes C Michaelian, Katharine Salmon, Jane Alty, Sharon L Naismith, Perminder S Sachdev\",\"doi\":\"10.1002/trc2.70031\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>A lack of national consensus on the roles and responsibilities of Australian memory and cognition clinics contributes to the large variability seen across services. The introduction of guidelines and a quality assessment framework could facilitate greater harmonization and quality improvements.</p><p><strong>Methods: </strong>We used a modified Delphi process to develop the guidelines. Pilot clinics completed a self-assessment, case-note audit, and review meeting to evaluate their service against the guidelines.</p><p><strong>Results: </strong>The final guidelines included 160 standards on 14 different topics. Standards around maximum waiting times for an assessment and minimum post-diagnostic care responsibilities were particularly controversial. Seven clinics participated in the pilot. On average, clinics achieved 56% of standards (range of 18% to 87%).</p><p><strong>Discussion: </strong>The Memory and Cognition Clinic Guidelines form the first step toward greater harmonization and quality improvements. Key learnings from the clinics' feedback included reducing the number of secondary standards and streamlining data collection with the national dementia clinical quality registry.</p><p><strong>Highlights: </strong>We developed and implemented the first national consensus-based best-practice guidelines for memory and cognition clinics in Australia.The guidelines are based on consultation with 125 Australian health professionals and 89 Australians living with dementia and care partners.First-time national agreement on standards around maximum waiting times for an assessment and minimum post-diagnostic care requirements is presented in the guidelines.The guidelines were implemented in seven memory and cognition clinics from five different states.Clinicians' feedback included: reducing the number of secondary standards to increase conciseness and practicability should be considered for future iterations.</p>\",\"PeriodicalId\":53225,\"journal\":{\"name\":\"Alzheimer''s and Dementia: Translational Research and Clinical Interventions\",\"volume\":\"11 1\",\"pages\":\"e70031\"},\"PeriodicalIF\":4.9000,\"publicationDate\":\"2025-01-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11736619/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Alzheimer''s and Dementia: Translational Research and Clinical Interventions\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1002/trc2.70031\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q1\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alzheimer''s and Dementia: Translational Research and Clinical Interventions","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/trc2.70031","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
Developing, implementing, and evaluating the first national Memory and Cognition Clinic Guidelines in Australia.
Introduction: A lack of national consensus on the roles and responsibilities of Australian memory and cognition clinics contributes to the large variability seen across services. The introduction of guidelines and a quality assessment framework could facilitate greater harmonization and quality improvements.
Methods: We used a modified Delphi process to develop the guidelines. Pilot clinics completed a self-assessment, case-note audit, and review meeting to evaluate their service against the guidelines.
Results: The final guidelines included 160 standards on 14 different topics. Standards around maximum waiting times for an assessment and minimum post-diagnostic care responsibilities were particularly controversial. Seven clinics participated in the pilot. On average, clinics achieved 56% of standards (range of 18% to 87%).
Discussion: The Memory and Cognition Clinic Guidelines form the first step toward greater harmonization and quality improvements. Key learnings from the clinics' feedback included reducing the number of secondary standards and streamlining data collection with the national dementia clinical quality registry.
Highlights: We developed and implemented the first national consensus-based best-practice guidelines for memory and cognition clinics in Australia.The guidelines are based on consultation with 125 Australian health professionals and 89 Australians living with dementia and care partners.First-time national agreement on standards around maximum waiting times for an assessment and minimum post-diagnostic care requirements is presented in the guidelines.The guidelines were implemented in seven memory and cognition clinics from five different states.Clinicians' feedback included: reducing the number of secondary standards to increase conciseness and practicability should be considered for future iterations.
期刊介绍:
Alzheimer''s & Dementia: Translational Research & Clinical Interventions (TRCI) is a peer-reviewed, open access,journal from the Alzheimer''s Association®. The journal seeks to bridge the full scope of explorations between basic research on drug discovery and clinical studies, validating putative therapies for aging-related chronic brain conditions that affect cognition, motor functions, and other behavioral or clinical symptoms associated with all forms dementia and Alzheimer''s disease. The journal will publish findings from diverse domains of research and disciplines to accelerate the conversion of abstract facts into practical knowledge: specifically, to translate what is learned at the bench into bedside applications. The journal seeks to publish articles that go beyond a singular emphasis on either basic drug discovery research or clinical research. Rather, an important theme of articles will be the linkages between and among the various discrete steps in the complex continuum of therapy development. For rapid communication among a multidisciplinary research audience involving the range of therapeutic interventions, TRCI will consider only original contributions that include feature length research articles, systematic reviews, meta-analyses, brief reports, narrative reviews, commentaries, letters, perspectives, and research news that would advance wide range of interventions to ameliorate symptoms or alter the progression of chronic neurocognitive disorders such as dementia and Alzheimer''s disease. The journal will publish on topics related to medicine, geriatrics, neuroscience, neurophysiology, neurology, psychiatry, clinical psychology, bioinformatics, pharmaco-genetics, regulatory issues, health economics, pharmacoeconomics, and public health policy as these apply to preclinical and clinical research on therapeutics.